Sage Therapeutics to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

Sage Therapeutics, Inc. (Nasdaq: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that it will host a live webcast on Tuesday, November 7, 2023 at 8:00 a.m. ET to review third quarter 2023 financial results and discuss recent business updates.

The webcast can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcast will be available following the completion of the event and will be archived for up to 30 days.

About Sage Therapeutics

Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.

Contacts

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  220.59
+2.64 (1.21%)
AAPL  259.91
+1.46 (0.56%)
AMD  235.36
+5.13 (2.23%)
BAC  51.70
+0.60 (1.18%)
GOOG  255.20
+2.67 (1.06%)
META  735.47
+2.06 (0.28%)
MSFT  523.08
+2.54 (0.49%)
NVDA  182.85
+2.57 (1.43%)
ORCL  282.68
+10.02 (3.67%)
TSLA  446.64
+7.67 (1.75%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.